查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1448021

牛初乳市場 - 2023-2030

Cow Colostrum Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 210 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2022年，全球牛初乳市場達到12億美元，預計2030年將達到18億美元，2023-2030年預測期間CAGR為5.2%。

預計 2024 年至 2031 年期間，對牛初乳的需求將顯著上升，

由於牛初乳卓越的營養成分和高水平的抗體，消費者擴大將牛初乳涵蓋各種應用，特別是嬰兒產品中。這些抗體在預防感染和促進嬰兒和動物的健康成長方面發揮著至關重要的作用。此外，牛初乳因其豐富的必需營養素和蛋白質而受到重視。

此外，製造公司正在透過引入創新的牛初乳產品來實現產品組合多元化，這項策略旨在擴大其市場規模並擴大其市場佔有率。例如，2022年11月，PanTheryx公司推出了新的Life's First Naturals PRO牛初乳補充劑，它由免疫因子、保護性蛋白質、生長因子和益生元的綜合來源ColostrumOne提供動力。

營養和膳食補充劑領域在全球牛初乳市場中佔最大佔有率。同樣，亞太地區一直是主導力量，因為該地區的牛奶生產率很高，而且製造商也在開發創新的牛初乳產品，這有助於推動全球牛初乳市場。

動力學

初乳腺癌盛行率增加

益生菌紊亂可導致初乳腺癌，而消費者中初乳腺癌的盛行率正在上升。例如，根據世界衛生組織 (WHO) 的報告，大腸癌是全球第三大常見癌症，約佔所有癌症病例的 10%，也是全球癌症相關死亡的第二大原因。它主要影響老年人，大多數病例發生在 50 歲及以上的人群中。

此外，製造公司正致力於開發各種產品以吸引更大的消費者群。例如，2022年11月，APS Bio Group和Sunplus宣佈建立多年策略夥伴關係，共同開發新的牛初乳產品。透過此策略合作，APS 將在 sunplus 的 natrapure cbps 奶粉中首次推​​出其新的初乳鹼性蛋白和免疫球蛋白配方。

增加產品開發

產品開發人員正在將牛初乳添加到各種功能性食品和膳食補充劑中，因為牛初乳以其高營養含量（包括蛋白質和維生素）而聞名。它提供有助於免疫系統支持的抗體。因此，產品開發有助於推動全球牛初乳市場。

此外，各大公司都在策略性地開發和擴大初乳市場。例如，2022 年 12 月，Blendhub 和 ColoPlus AB 之間的合作創新推出了基於牛初乳的 ColoPlus 配方，幫助癌症或愛滋病患者、頂級運動員或老年人恢復免疫系統。此次合作旨在開發和商業化基於牛初乳和天然營養的生物活性特性的專利創新營養食品。

乳糖不耐症

有些消費者可能無法消化乳糖，他們無法消化以牛初乳為基礎的產品。乳糖不耐症的盛行率正在增加，例如，根據 2023 年的醫藥報告，大約 65% 的人口在嬰兒期後消化乳糖的能力下降，這在東亞地區最為常見。因此，如此高的盛行率可能會限制較小消費群的市場。

目錄

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 自然片段
  • 按產品類型分類的片段
  • 按應用程式片段
  • 按配銷通路分類的片段
  • 按地區分類的片段

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 初乳腺癌盛行率增加
      • 增加產品開發
    • 限制
      • 乳糖不耐症
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • DMI 意見

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章：本質

  • 有機的
  • 傳統的

第 8 章：依產品類型

  • 所有的
    • 全牛初乳粉
    • 脫脂初乳粉
    • 特種牛初乳粉
  • 初乳成品
    • 膠囊
    • 咀嚼片
    • 獨立小袋
    • 特殊配方產品

第 9 章：按應用

  • 食物
  • 化妝品
  • 營養和膳食補充劑
  • 其他

第 10 章：按配銷通路

  • 大型超市/超市
  • 便利商店
  • 專賣店
  • 藥局
  • 其他

第 11 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 俄羅斯
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 12 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 13 章：公司簡介

  • Colostrum BioTec GmbH
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Zuche Pharmaceuticals.
  • Biodane Pharma A/S
  • Agati Healthcare
  • mcePharma
  • Cure Nutraceutical PVT. LTD.
  • PanTheryx, Inc.
  • NOW Health Group, Inc.
  • Sterling Technology
  • Aadvik Foods

第 14 章：附錄

簡介目錄
Product Code: FB8082

Overview

Global Cow Colostrum Market reached US$ 1.2 billion in 2022 and is expected to reach US$ 1.8 billion by 2030, growing with a CAGR of 5.2% during the forecast period 2023-2030.

The demand for cow colostrum is rising significantly over the forecast period of 2024-2031,

Consumers are increasingly incorporating cow colostrum into a variety of applications, particularly in infant products, due to its exceptional nutritional content and high levels of antibodies. These antibodies play a crucial role to safeguard against infections and promoting healthy growth in both infants and animals. Additionally, cow colostrum is valued for its abundance of essential nutrients and proteins.

In addition, manufacturing companies are diversifying their portfolios by introducing innovative cow colostrum products, a strategy aimed at increasing their market sizes and expanding their market presence. For instance, in November 2022, PanTheryxcompany launched a new Life's First Naturals PRO bovine (cow) colostrum supplement, it is powered by ColostrumOne, a comprehensive source of immune factors, protective proteins, growth factors, and prebiotics.

The nutritional and dietary supplements segment accounts the largest share in global cow colostrum market. Similarly, Asia-Pacific region has been a dominant force as the production rate of milk is high in this region, as well as manufactures also developing innovative cow colostrum products, which can help in driving the global cow colostrum market.

Dynamics

Increasing Prevalence Of Colostrum Cancers

The probiotic disorder can cause colostrum cancer, and the prevalence of colostrum cancer is rising among consumers. For instance, according to a World Health Organization (WHO) report, colorectal cancer is the third most common cancer worldwide, accounting for approximately 10% of all cancer cases, and is the second leading cause of cancer-related deaths worldwide. It predominantly affects older individuals, with the majority of cases occurring in people aged 50 and above.

In addition, manufacturing companies are focusing on developing a wide range of products to attract larger consumer bases. For instance, in November 2022, APS Bio Group and Sunplus, announced a multi-year strategic partnership to develop new bovine colostrum products. Through the strategic partnership, APS will debut its new colostrum basic protein and immunoglobulin g formula in sunplus's natrapure cbps milk powder.

Increase in Product Development

Product developers are incorporating cow colostrum into various functional foods and dietary supplements, as cow colostrum is known for its high nutritional content, including proteins, and vitamins. It offers antibodies that contribute to immune system support. As a result product development can help in driving the global cow colostrum market.

Furthermore, major companies are strategically developing and expanding the colostrum market. For instance, in December 2022, collaborative innovation between Blendhub and ColoPlus AB launched a ColoPlus formula based on bovine colostrum to help restore the immune system in cancer or HIV patients, top athletes, or the elderly. This collaboration is to develop and commercialize patented innovative nutraceutical food products based on the bioactive properties of bovine colostrum and natural nutrition.

Lactose Intolerance

Some consumers might have an inability to digest the lactose, they are unable to digest cow-colostrum-based products. The prevalence of lactose intolerance is increasing, for instance, according to a pharma report of 2023, approximately 65 percent of the human population has a reduced ability to digest lactose after infancy, and it is most common in the East Asian region. Therefore, such a high prevalence rate can limit the market for smaller consumer bases.

Segment Analysis

The global cow colostrum market is segmented based on nature, product type, application, distribution channel, and region.

Increase in Demand for Effective Natural Organic Nutritional and Dietary Supplements

The nutritional and dietary supplements segment accounts for the largest share of the global cow colostrum market, consumers are adopting these cow colostrum as they are rich in immunoglobulins, antibodies that play a vital role in supporting the immune system. The regular consumption of colostrum supplements may help enhance the body's defense mechanisms against infections and illnesses.

Furthermore, supplement-producing companies are launching innovative products. For instance, in August 2022, the Roots Brands is unveiling a one-of-a-kind blend of hydrolyzed bovine collagen and whole colostrum powder as a youth-enhancing supplement, which is Dubbed Give Me Back My Youth (GMBMY), is sourced from cows. It helps to promote type types I and Ill collagen in humans, and also boosts skin hydration, enhancing suppleness and minimizing wrinkles.

Geographical Penetration

High Milk Production, and Product Development

Asia-Pacific has been a dominant force in the global cow colostrum market and its significant growth. From ancient times milk and milk products have been part of the consumer's diet in this region, also the demand for cow colostrum products is rising especially in infant foods as they provide antibodies and enhance the immune health.

Furthermore, the production rate for milk is high in this region, for instance, according to the Ministry of Fisheries, Animal Husbandry & Dairying reports the milk industry has raised, since the launch of Operation Flood program. India is the largest producer of milk in the world, contributing 23% of global milk production.

In addition, the manufacturing companies in this region are also launching products to support the rising market demand. For instance, in May 2020, the Surat District Cooperative Milk Producers Union Limited developed cow colostrum powder' Sumul Immune powder, an immunity booster to protect COVID-19-positive patients, it has albumin, globulin, and Gama globulin. It is rich in vitamins A, D, E, and K and also contains 300 types of enzymes to increase gut health.

Competitive Landscape

The major global players in the market include Colostrum BioTec GmbH, Zuche Pharmaceuticals., Biodane Pharma A/S, Agati Healthcare, mcePharma, Cure Nutraceutical PVT. LTD., PanTheryx, Inc., NOW Health Group, Inc., Sterling Technology, and Aadvik Foods.

COVID-19 Impact Analysis

The pandemic has had diverse effects on various markets, including the food and healthcare sectors. Many governments have imposed lockdown restrictions which has disrupted the supply chain, changes in consumer behavior, and economic challenges can influence markets. Hence, COVID-19 has shown a negative impact global cow colostrum market.

By Nature

  • Organic
  • Conventional

By Product Type

  • Whole
  • Whole Colostrum Powder
  • Skim Colostrum Powder
  • Specialty Colostrum Powder
  • Colostrum Finished Products
  • Capsules
  • Chewable Tablets
  • Individual Sachets
  • Specially Formulated Products

By Application

  • Food
  • Cosmetics
  • Nutritional and Dietary Supplements
  • Others

By Distribution Channel

  • Hypermarket/Supermarket
  • Convenience Store
  • Specialty Stores
  • Drug Stores
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In May 2022, Glanbia Nutritionals acquired Sterling Technology, a South Dakota-based manufacturer of dairy bioactive solutions derived from bovine colostrum. Glanbia Nutritionals purchased for $60 million plus deferred consideration.
  • In November 2022, PanTheryx launches extra- strength colostrum supplement which is Life's First Naturals PRO, an extra-strength immune support and digestive health supplement formulated for the health care practitioner channel.

Why Purchase the Report?

  • To visualize the global cow colostrum market segmentation based on nature, product type, application, distribution channel, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of cow colostrum market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global cow colostrum market report would provide approximately 70 tables, 63 figures and 210 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Nature
  • 3.2.Snippet by Product Type
  • 3.3.Snippet by Application
  • 3.4.Snippet by Distribution Channel
  • 3.5.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Increasing Prevalence of Colostrum Cancers
      • 4.1.1.2.Increase in Product Development
    • 4.1.2.Restraints
      • 4.1.2.1.Lactose Intolerance
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Nature

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 7.1.2.Market Attractiveness Index, By Nature
  • 7.2.Organic*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Conventional

8.By Product Type

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2.Market Attractiveness Index, By Product Type
  • 8.2.Whole*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.3.Whole Colostrum Powder
    • 8.2.4. Skim Colostrum Powder
    • 8.2.5. Specialty Colostrum Powder
  • 8.3.Colostrum Finished Products
    • 8.3.1.Capsules
    • 8.3.2.Chewable Tablets
    • 8.3.3.Individual Sachets
    • 8.3.4. Specially Formulated Products

9.By Application

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2.Market Attractiveness Index, By Application
  • 9.2.Food*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Cosmetics
  • 9.4.Nutritional and Dietary Supplements
  • 9.5.Others

10.By Distribution Channel

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.1.2.Market Attractiveness Index, By Distribution Channel
  • 10.2.Hypermarket/Supermarket*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Convenience Store
  • 10.4.Specialty Stores
  • 10.5.Drug Stores
  • 10.6.Others

11.By Region

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2.Market Attractiveness Index, By Region
  • 11.2.North America
    • 11.2.1.Introduction
    • 11.2.2.Key Region-Specific Dynamics
    • 11.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1.U.S.
      • 11.2.7.2.Canada
      • 11.2.7.3.Mexico
  • 11.3.Europe
    • 11.3.1.Introduction
    • 11.3.2.Key Region-Specific Dynamics
    • 11.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1.Germany
      • 11.3.7.2.UK
      • 11.3.7.3.France
      • 11.3.7.4.Italy
      • 11.3.7.5.Russia
      • 11.3.7.6.Rest of Europe
  • 11.4.South America
    • 11.4.1.Introduction
    • 11.4.2.Key Region-Specific Dynamics
    • 11.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1.Brazil
      • 11.4.7.2.Argentina
      • 11.4.7.3.Rest of South America
  • 11.5.Asia-Pacific
    • 11.5.1.Introduction
    • 11.5.2.Key Region-Specific Dynamics
    • 11.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1.China
      • 11.5.7.2.India
      • 11.5.7.3.Japan
      • 11.5.7.4.Australia
      • 11.5.7.5.Rest of Asia-Pacific
  • 11.6.Middle East and Africa
    • 11.6.1.Introduction
    • 11.6.2.Key Region-Specific Dynamics
    • 11.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12.Competitive Landscape

  • 12.1.Competitive Scenario
  • 12.2.Market Positioning/Share Analysis
  • 12.3.Mergers and Acquisitions Analysis

13.Company Profiles

  • 13.1.Colostrum BioTec GmbH*
    • 13.1.1.Company Overview
    • 13.1.2.Product Portfolio and Description
    • 13.1.3.Financial Overview
    • 13.1.4.Key Developments
  • 13.2.Zuche Pharmaceuticals.
  • 13.3.Biodane Pharma A/S
  • 13.4.Agati Healthcare
  • 13.5.mcePharma
  • 13.6.Cure Nutraceutical PVT. LTD.
  • 13.7.PanTheryx, Inc.
  • 13.8.NOW Health Group, Inc.
  • 13.9.Sterling Technology
  • 13.10.Aadvik Foods

LIST NOT EXHAUSTIVE

14.Appendix

  • 14.1.About Us and Services
  • 14.2.Contact Us